Alessandro Comandone

5.1k total citations · 1 hit paper
103 papers, 3.0k citations indexed

About

Alessandro Comandone is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Alessandro Comandone has authored 103 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Pulmonary and Respiratory Medicine, 59 papers in Oncology and 29 papers in Pathology and Forensic Medicine. Recurrent topics in Alessandro Comandone's work include Sarcoma Diagnosis and Treatment (60 papers), Vascular Tumors and Angiosarcomas (29 papers) and Bone Tumor Diagnosis and Treatments (10 papers). Alessandro Comandone is often cited by papers focused on Sarcoma Diagnosis and Treatment (60 papers), Vascular Tumors and Angiosarcomas (29 papers) and Bone Tumor Diagnosis and Treatments (10 papers). Alessandro Comandone collaborates with scholars based in Italy, Spain and United Kingdom. Alessandro Comandone's co-authors include Piero Picci, Stefano Ferrari, A. Tienghi, S. Frustaci, Gaetano Bacci, Mario Mercuri, Alessandra Longhi, Antonino De Paoli, Adalberto Brach del Prever and Elena Barbieri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Alessandro Comandone

98 papers receiving 3.0k citations

Hit Papers

Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of t... 2001 2026 2009 2017 2001 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial
    2001 506 citations S. Frustaci, Antonino De Paoli et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandro Comandone Italy 25 2.3k 1.4k 913 621 539 103 3.0k
Federica Grosso Italy 33 3.0k 1.3× 1.8k 1.3× 633 0.7× 535 0.9× 621 1.2× 158 4.4k
Gunnar Sæter Norway 33 2.4k 1.0× 1.3k 0.9× 1.0k 1.1× 646 1.0× 507 0.9× 77 3.4k
Thor Alvegård Sweden 33 2.7k 1.2× 1.6k 1.2× 898 1.0× 837 1.3× 669 1.2× 81 3.3k
James E. Butrynski United States 26 2.0k 0.9× 1.2k 0.9× 738 0.8× 506 0.8× 410 0.8× 52 3.3k
A Briccoli Italy 35 2.8k 1.2× 996 0.7× 1.4k 1.5× 920 1.5× 572 1.1× 82 3.6k
Dominique Ranchère‐Vince France 32 3.0k 1.3× 1.4k 1.0× 1.2k 1.3× 526 0.8× 662 1.2× 89 3.9k
Mary Louise Keohan United States 34 2.8k 1.2× 2.2k 1.6× 718 0.8× 354 0.6× 627 1.2× 105 4.4k
Adrián Mariño‐Enríquez United States 35 2.2k 1.0× 861 0.6× 1.1k 1.2× 447 0.7× 215 0.4× 94 3.6k
Philippe Terrier France 31 2.2k 0.9× 963 0.7× 1.2k 1.4× 404 0.7× 452 0.8× 60 3.3k
A. Tienghi Italy 23 1.7k 0.7× 892 0.6× 694 0.8× 508 0.8× 422 0.8× 54 2.3k

Countries citing papers authored by Alessandro Comandone

Since Specialization
Citations

This map shows the geographic impact of Alessandro Comandone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Comandone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Comandone more than expected).

Fields of papers citing papers by Alessandro Comandone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Comandone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Comandone. The network helps show where Alessandro Comandone may publish in the future.

Co-authorship network of co-authors of Alessandro Comandone

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Comandone. A scholar is included among the top collaborators of Alessandro Comandone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Comandone. Alessandro Comandone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olimpieri, Pier Paolo, et al.. (2024). Pazopanib in the real-world setting in soft tissue sarcomas: data from the Italian national registry. ESMO Open. 9(12). 103995–103995.
2.
Franzoi, Isabella Giulia, et al.. (2023). The psychological impact of sarcoma on affected patients. Psycho-Oncology. 32(12). 1787–1797. 5 indexed citations
3.
Manini, Claudia, et al.. (2023). Benign Mesothelial Proliferations of the Tunica Vaginalis Testis. SHILAP Revista de lepidopterología. 13(5). 1130–1136.
4.
Zagami, Paola, Alessandro Comandone, Marco Fiore, et al.. (2023). The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers. Cancer Medicine. 12(16). 17047–17055. 2 indexed citations
5.
Fenoglio, Roberta, Martina Cozzi, Savino Sciascia, et al.. (2023). The need for kidney biopsy in the management of side effects of target and immunotherapy. SHILAP Revista de lepidopterología. 3. 2 indexed citations
6.
Vincenzi, Bruno, Andrea Napolitano, Alessandro Comandone, et al.. (2022). Trabectedin use in soft‐tissue sarcoma patients in a real‐world setting: Data from an Italian national drug‐access registry. International Journal of Cancer. 152(4). 761–768. 9 indexed citations
7.
Pizzato, Margherita, Giulia Collatuzzo, Claudia Santucci, et al.. (2022). Mortality patterns of soft-tissue sarcomas worldwide up to 2018, with predictions for 2025. European Journal of Cancer Prevention. 32(1). 71–80. 4 indexed citations
8.
Baratta, Francesca, Pietro Quaglino, Alessandro Comandone, et al.. (2022). The importance of a multidisciplinary care: community pharmacies as a hub to support oncologic patients with cutaneous reactions due to treatments. Italian Journal of Dermatology and Venereology. 156. 1 indexed citations
9.
Palmerini, Emanuela, Elisabetta Setola, Giovanni Grignani, et al.. (2020). High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series. Cells. 9(11). 2389–2389. 25 indexed citations
10.
Rossi, L, Michele Boffano, Alessandro Comandone, et al.. (2020). Validation process of Toronto Exremity Salvage Score in Italian: A quality of life measure for patients with extremity bone and soft tissue tumors. Journal of Surgical Oncology. 121(4). 630–637. 9 indexed citations
11.
Joensuu, Heikki, Jean‐Yves Blay, Alessandro Comandone, et al.. (2017). Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib. British Journal of Cancer. 117(9). 1278–1285. 33 indexed citations
12.
Comandone, Alessandro & Antonella Boglione. (2015). Importanza delle mutazioni nella prognosi e terapia medica dei GIST. Recenti Progressi in Medicina. 106(1). 17–22. 10 indexed citations
13.
Palmerini, Emanuela, Piero Picci, Emanuela Marchesi, et al.. (2015). High dose ifosfamide in metastatic high-grade osteosarcoma, after failure of standard multimodal chemotherapy.. Journal of Clinical Oncology. 33(15_suppl). 10527–10527. 2 indexed citations
14.
Joensuu, Heikki, Jean‐Yves Blay, Alessandro Comandone, et al.. (2014). Phase 2 Trial to Evaluate the Efficacy and Safety of Dovitinib in Patients (Pts) with Gastrointestinal Stromal Tumor (Gist) Refractory and/or Intolerant to Imatinib (Im). Annals of Oncology. 25. v1–v1. 2 indexed citations
15.
Gronchi, Alessandro, S. Frustaci, Mario Mercuri, et al.. (2012). Short, Full-Dose Adjuvant Chemotherapy in High-Risk Adult Soft Tissue Sarcomas: A Randomized Clinical Trial From the Italian Sarcoma Group and the Spanish Sarcoma Group. Journal of Clinical Oncology. 30(8). 850–856. 120 indexed citations
16.
Bertuzzi, Alexia, Elisa Maria Stroppa, Simona Secondino, et al.. (2009). 9430 Efficacy and toxicity of sorafenib in patients with advanced soft tissue sarcoma failing anthracycline-based chemotherapy. European Journal of Cancer Supplements. 7(2). 599–599. 1 indexed citations
17.
Santoro, Armando, Alessandro Comandone, Lorenza Rimassa, et al.. (2008). A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer. Annals of Oncology. 19(11). 1888–1893. 42 indexed citations
18.
Gelormino, Elena, Eva Pagano, Manuela Ceccarelli, et al.. (2007). [Adapting clinical practice guidelines to a regional oncology network: the Piedmont experience].. PubMed. 31(1). 25–33. 1 indexed citations
19.
Comandone, Alessandro, et al.. (1998). Pharmacokinetics of Ifosfamide Administered According to Three Different Schedules in Metastatic Soft Tissue and Bone Sarcomas. Journal of Chemotherapy. 10(5). 385–393. 13 indexed citations
20.
Rovea, P, et al.. (1997). Radiation therapy and chemotherapy in the conservative treatment of carcinoma of the anal canal: survival and late morbidity in a series of 25 patients.. PubMed. 17(1B). 653–6. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Federica Grosso Breakdown of academic impact, for papers by Gunnar Sæter Breakdown of academic impact, for papers by Thor Alvegård Breakdown of academic impact, for papers by James E. Butrynski Breakdown of academic impact, for papers by A Briccoli Breakdown of academic impact, for papers by Dominique Ranchère‐Vince Breakdown of academic impact, for papers by Mary Louise Keohan Breakdown of academic impact, for papers by Adrián Mariño‐Enríquez Breakdown of academic impact, for papers by Philippe Terrier Breakdown of academic impact, for papers by A. Tienghi
Rankless by CCL
2026